ACADEMIC APPOINTMENTS

• 2022-Now｜Primary Investigator, Mind-Body Interface Center, China Medical University Hospital, Taichung, Taiwan    台中中國醫藥大學 身心介面研究中心 計畫主持人
• 2016-2022｜Researcher, Mind-Body Interface Center, China Medical University Hospital, Taichung, Taiwan    台中中國醫藥大學 身心介面研究中心 研究員
• 1998-2017｜Senior Lecturer, School of Health Care Administration, Taipei Medical University, Taiwan  台北醫學大學醫務管理學系 資深講師

EDUCATION

• PhD in Health Economics, Institute of Psychiatry-King's College London, UK 英國倫敦國王學院 博士

PROFESSIONAL EXPERIENCES

• 2016-Now    Secretary-General, Taiwanese Society for Nutritional Psychiatry Research (TSNPR), Taiwan  台灣營養精神醫學研究學會 秘書長
• 2010-Now    Executive Secretary, Mind-Body Interface International Symposium  身心介面國際研討會 執行總召

RESEARCH INTERESTS

• Health Service Research  醫療健康照護研究
• Economic Evaluation in Health Care  醫療經濟評估
• Pharmacoepidemiology & Pharmacoeconomics  藥物流行病學及藥物經濟學 
• Health Outcome Research  臨床實效研究
• Health Organization and Management  健康照護機構管理

PUBLICATIONS

1. Pham A.T.N., Chang, H.C*., Chiu, W.C., Huang, K.C., Tang , C.H., Su, K.P.  Change of employment status in patients with depression – A longitudinal study using national claims data (in submission).
2. Su, K.P., Lu, N., Tang, C.H., Chiu, W.C., Chang, H.C., Huang, K.C. (2019) Comparisons of the risk of medication noncompliance and suicidal behavior among patients with depressive disorders using different monotherapy antidepressants in Taiwan: A nationwide population-based retrospective cohort study. Journal of Affective Disorders, 250(1): 170-177
3. Su, K.P., Tang, C.H., Chang, H.C., Chiu, W.C., Lu, N., Huang, K.C. (2019). Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan. International Clinical Psychopharmacology, 34(4):170-178
4. Chang, H.C., Huang, K.C., Chui, W.C., Huang, K.C., Tang, C.H, Su, K.P. (2016). Changes in employment status in bipolar disorders: a 10-­year longitudinal study using national claims data. Journal of Clinical Psychiatry, 77(4): e429-35
5. Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JPC, Huang CL, Chang HC, Pariante CM (2014). Omega-3 fatty acids in the prevention of interferonalpha-induced depression Results from a randomized, controlled trial. Biological Psychiatry, 76(7): 559-66
6. Chang, H.C., Tang C.H., Huang, S.T., McCrone, P., Su, K.P., (2012). A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: a one-year mirror image study with national claim-based database in Taiwan. Journal of Psychiatric Research, 46: 751-756
7. Patel, A., Maissi, E., Chang, H.C., Rodrigues, I., Smith, M., Thomas, S., Chalder, T., Schmidt, U., Treasure, J., Ismail, K. (2011). Motivational enhancement therapy with and without cognitive behaviour therapy for Type 1 diabetes: economic evaluation from a randomized controlled trial. Diabetic Medicine, 28(4): 470-479
8. Su K.P., Chang, H.C., Tsai, S.J, Yen, F.C., Tang C. H. (2009). Relapse and long-acting injectable Risperidone: A 1-year mirror image study with a national claims database in Taiwan. Value in Health, 12(s3): s118-s121
9. Chang, H.C., Tang, C.H., Tsai, S.J., Yen, F.C., Su, K.P. (2009). Long-acting injectable risperidone and hospital readmission: A mirror image study with a national claim-based database in Taiwan. The Journal of Clinical Psychiatry, 70(1): 141

huichih.chang@gmail.com